SCHEDULE III(Sections 2, 4 to 7.1, 10, 29, 55 and 60)
1
[Repealed, 2012, c. 1, s. 45]
2
Methylphenidate (methyl 2-phenyl-2-(piperidin-2-yl)acetate), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues, including
Methaqualone (2–methyl–3–(2–methylphenyl)–4(3H)–quinazolinone) and any salt thereof
4
Mecloqualone (2–methyl–3–(2–chlorophenyl)–4(3H)–quinazolinone) and any salt thereof
5
Lysergic acid diethylamide (LSD) (N,N–diethyllysergamide) and any salt thereof
6
N,N–Diethyltryptamine (DET) (3–[(2–diethylamino) ethyl]indole) and any salt thereof
7
N,N–Dimethyltryptamine (DMT) (3–[(2–dimethylamino) ethyl]indole) and any salt thereof
8
N–Methyl–3–piperidyl benzilate (LBJ) (3–[(hydroxydiphenylacetyl)oxy]–1–methylpiperidine) and any salt thereof
9
Harmaline (4,9–dihydro–7–methoxy–1–methyl–3H–pyrido(3,4–b)indole) and any salt thereof
10
Harmalol (4,9–dihydro–1–methyl–3H–pyrido(3,4–b)indol–7–ol) and any salt thereof
11
Psilocin (3–[2–(dimethylamino)ethyl]–4–hydroxyindole) and any salt thereof
12
Psilocybin (3–[2–(dimethylamino)ethyl]–4–phosphoryloxyindole) and any salt thereof
13
N–(1–phenylcyclohexyl)ethylamine (PCE) and any salt thereof
14
1–[1–(2–Thienyl) cyclohexyl]piperidine (TCP) and any salt thereof
15
1–Phenyl–N–propylcyclohexanamine and any salt thereof
16
Rolicyclidine (1-(1-phenylcyclohexyl) pyrrolidine) and any salt thereof
17
Mescaline (3,4,5–trimethoxybenzeneethanamine) and any salt thereof, but not peyote (lophophora)
18
4–Methylaminorex (4,5–dihydro–4–methyl–5–phenyl–2–oxazolamine) and any salt thereof
19
Cathinone ((-)-α-aminopropiophenone) and its salts
20
Fenetylline (d,l–3,7–dihydro–1,3–dimethyl–7–(2–[(1–methyl–2–phenethyl)amino]ethyl)–1H–purine–2, 6–dione) and any salt thereof
21
2–Methylamino–1–phenyl–1–propanone and any salt thereof
22
1–[1–(Phenylmethyl)cyclohexyl]piperidine and any salt thereof
23
1–[1–(4–Methylphenyl)cyclohexyl]piperidine and any salt thereof
24
[Repealed, SOR/2016-73, s. 1]
25 and 26
[Repealed, 2012, c. 1, s. 46]
27
Aminorex (4,5-dihydro-5-phenyl-2-oxazolamine) and any salt thereof
28
Etryptamine (3-(2-aminobutyl)indole) and any salt thereof
29
Lefetamine ((-)-N,N-dimethyl-α-phenylbenzeneethanamine), its salts, derivatives and isomers and salts of derivatives and isomers
30
Mesocarb (3-(α-methylphenethyl)-N-(phenylcarbamoyl)sydnone imine) and any salt thereof
31
Zipeprol (4-(2-methoxy-2-phenylethyl)-α-(methoxyphenylmethyl)-1-piperazineethanol) and any salt thereof
32
Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) and any salt thereof
33
Benzylpiperazine [BZP], namely 1-benzylpiperazine and its salts, isomers and salts of isomers
34
Trifluoromethylphenylpiperazine [TFMPP], namely 1-(3-trifluoromethylphenyl)piperazine and its salts, isomers and salts of isomers
35
2C-phenethylamines and their salts, derivatives, isomers and salts of derivatives and isomers that correspond to the following chemical description :
any substance that has a 1-amino-2-phenylethane structure substituted at the 2’ and 5’ or 2’ and 6’ positions of the benzene ring by an alkoxy or haloalkoxy group, or substituted at two adjacent carbon atoms of the benzene ring which results in the formation of a furan, dihydrofuran, pyran, dihydropyran or methylenedioxy group — whether or not further substituted on the benzene ring to any extent, whether or not substituted at the amino group by one or two, or a combination of, methyl, ethyl, propyl, isopropyl, hydroxyl, benzyl (or benzyl substituted to any extent) or benzylene (or benzylene substituted to any extent) groups and whether or not substituted at the 2-ethyl (beta carbon) position by a hydroxyl, oxo or alkoxy group — and its salts and derivatives and salts of derivatives, including
